Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123894152 | 12389415 | 2 | F | 20160429 | 20160810 | 20160520 | 20160817 | EXP | GB-MHRA-EYC 00139381 | GB-GLAXOSMITHKLINE-GB2016069089 | GLAXOSMITHKLINE | 11.00 | YR | M | Y | 54.00000 | KG | 20160817 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123894152 | 12389415 | 1 | PS | Aciclovir | ACYCLOVIR | 1 | Intravenous (not otherwise specified) | 800 MG, UNK, 500MG/SQM | Y | 18603 | 800 | MG | |||||||
| 123894152 | 12389415 | 2 | SS | GENTAMICIN. | GENTAMICIN | 1 | Intravenous (not otherwise specified) | 100 MG, UNK | Y | 0 | 100 | MG | |||||||
| 123894152 | 12389415 | 3 | C | NICOTINAMIDE + PYRIDOXINE HYDROCHLORIDE + RIBOFLAVIN | 2 | UNK | U | 0 | |||||||||||
| 123894152 | 12389415 | 4 | C | FLUDROCORTISONE | FLUDROCORTISONE | 1 | UNK | U | 0 | ||||||||||
| 123894152 | 12389415 | 5 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | U | 0 | ||||||||||
| 123894152 | 12389415 | 6 | C | INFANT GAVISCON (ALGINIC ACID + ALUMINIUM HYDROXIDE + MAGNESIUM TRISIL | 2 | UNK | U | 0 | |||||||||||
| 123894152 | 12389415 | 7 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | UNK | U | 0 | ||||||||||
| 123894152 | 12389415 | 8 | C | PARACETAMOL | ACETAMINOPHEN | 1 | UNK | U | 0 | ||||||||||
| 123894152 | 12389415 | 9 | C | POTASSIUM CITRATE. | POTASSIUM CITRATE | 1 | UNK | U | 0 | ||||||||||
| 123894152 | 12389415 | 10 | C | PYRIDOXINE | PYRIDOXINE | 1 | UNK | U | 0 | ||||||||||
| 123894152 | 12389415 | 11 | C | SODIUM FEREDETATE | SODIUM FEREDETATE | 1 | UNK | U | 0 | ||||||||||
| 123894152 | 12389415 | 12 | C | TEICOPLANIN | TEICOPLANIN | 1 | Intravenous (not otherwise specified) | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123894152 | 12389415 | 1 | Herpes zoster |
| 123894152 | 12389415 | 2 | Lower respiratory tract infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123894152 | 12389415 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123894152 | 12389415 | Acute kidney injury | |
| 123894152 | 12389415 | Incorrect dose administered |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123894152 | 12389415 | 1 | 20160428 | 20160430 | 0 | |
| 123894152 | 12389415 | 2 | 20160428 | 20160429 | 0 |